| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |